Viewing Study NCT01213095


Ignite Creation Date: 2025-12-24 @ 1:48 PM
Ignite Modification Date: 2025-12-29 @ 12:21 PM
Study NCT ID: NCT01213095
Status: COMPLETED
Last Update Posted: 2016-04-11
First Post: 2010-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)
Sponsor: Dong-A University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module